Disseminated and Central Nervous System Vaccine-Strain Herpes Zoster Infection in a Teenager With Crohn’s Disease on Maintenance Adalimumab Therapy

D’Arienzo, David; Gryte, Kailas Rumjahn; Noya, Francisco; Morinville, Véronique D.

doi:10.1097/pg9.0000000000000072

Cited by 2 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several cases described this phenomenon in pediatric subjects. [10][11][12][13][14][15][16][17][18][19][20] These cases described the following: Breakthrough varicella in previously undiagnosed primary immunode ciency (NK T cell de ciency, SCID), occurring 2-5 weeks post-vaccination. [10][11][12][13][14] Breakthrough varicella in neonates postpartum due to unclear / vertical transmission from a vaccinated mother.…”

Section: Case Presentationmentioning

confidence: 99%

“…The most comparable case described disseminated herpes zoster with meningitis in a patient with known Crohn's disease, 15 years after receiving a single varicella vaccine. 20 This case summarizes the clinical course of an atypical infection in a pediatric patient with secondary immunode ciency (Hodgkin's lymphoma). When caring for a patient exhibiting such a rare phenomenon, the importance of the following is emphasized: Broad differential (wild-type varicella, herpes zoster, HSV, Oka-strain varicella)…”

Section: Case Presentationmentioning

confidence: 99%

See 1 more Smart Citation

Remote Disseminated Vaccine-Strain Varicella-Zoster Virus in an Adolescent with Secondary Immunodeficiency: A Case Report and Literature Review

Fashina,

Chuang,

Galardy

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Routine childhood immunization against varicella-zoster virus has led to a dramatic reduction in the incidence of primary varicella. However, there are rare, yet significant cases reported of reactivated Oka-strain varicella, primarily in immunocompromised hosts.Case Presentation A 16-year-old female with Hodgkin’s lymphoma developed a tender vesicular rash shortly after completing chemotherapy. Swabs obtained from the vesicles were positive for varicella-zoster virus. By the time of hospitalization, the patient developed a disseminated rash involving multiple dermatomes. Subsequent polymerase chain reaction confirmed Oka vaccine-strain varicella-zoster virus. The patient had previously received a primary series against varicella in 2008 and 2012, 11 years before her diagnosis of Hodgkin’s lymphoma. The patient was treated with parenteral acyclovir upon hospitalization and was monitored clinically for cutaneous disease progression as well as sequelae. After 8 days of inpatient treatment, her rash had stopped spreading with no new lesions. All earlier lesions had crusted over. No serious sequelae of disease such as pneumonitis, hepatitis, encephalitis, or meningitis occurred, and she made a complete recovery.Conclusions There are individual and community-wide benefits to childhood immunization against varicella. This case highlights an unusual presentation of disseminated vaccine-strain varicella-zoster virus in an adolescent with secondary immunodeficiency 11 years after completing primary immunization. In addition, this case informs pediatricians of complications that can arise in immunized subjects if they become immunosuppressed years later. Providers should be cognizant of potential vaccine virus reactivation in their differential. Considerations for work-up and management should include infection control and viral resistance in refractory cases.

show abstract